# Mit Patel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mit-patel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,401 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | Health Economics and Outcomes Research (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5043353465 |
| Works | 33 |

## Researcher papers

- [SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters](https://scholariq.org/papers/sars-cov-2-omicron-virus-causes-attenuated-disease-in-mice-and-hamsters/)
- [mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron](https://scholariq.org/papers/mrna-1273-or-mrna-omicron-boost-in-vaccinated-macaques-elicits-similar-b-cell/)
- [Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant](https://scholariq.org/papers/rapid-decline-in-vaccine-boosted-neutralizing-antibodies-against-sars-cov-2-2/)
- [The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters](https://scholariq.org/papers/the-sars-cov-2-b-1-1-529-omicron-virus-causes-attenuated-infection-and-disease/)
- [mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron](https://scholariq.org/papers/mrna-1273-or-mrna-omicron-boost-in-vaccinated-macaques-elicits-comparable-b-cell/)
- [Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant](https://scholariq.org/papers/antibody-response-to-covid-19-mrna-vaccine-in-patients-with-lung-cancer-after/)
- [Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants](https://scholariq.org/papers/immunogenicity-of-nvx-cov2373-heterologous-boost-against-sars-cov-2-variants/)
- [Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults](https://scholariq.org/papers/loss-of-pfizer-bnt162b2-vaccine-induced-antibody-responses-against-the-sars-cov/)
- [Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern](https://scholariq.org/papers/antibody-response-to-sars-cov-2-mrna-vaccine-in-lung-cancer-patients-reactivity/)
- [Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States](https://scholariq.org/papers/cost-effectiveness-analysis-of-nefecon-versus-best-supportive-care-for-people/)
- [Real-world challenges associated with the use of four common systemic glucocorticoids in a United States IgAN cohort](https://scholariq.org/papers/real-world-challenges-associated-with-the-use-of-four-common-systemic/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 detection and testing](https://scholariq.org/topics/sars-cov-2-detection-and-testing/)
- [Viral gastroenteritis research and epidemiology](https://scholariq.org/topics/viral-gastroenteritis-research-and-epidemiology/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Health Economics and Outcomes Research (United Kingdom)](https://scholariq.org/institutions/health-economics-and-outcomes-research-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.